» Articles » PMID: 37097523

Risk Factors for Severe COVID-19 in the Young-before and After ICU Admission

Overview
Specialty Critical Care
Date 2023 Apr 25
PMID 37097523
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Factors associated with severe COVID-19 and death among young adults are not fully understood, including differences between the sexes. The aim of this study was to identify factors associated with severe COVID-19 requiring intensive care and 90-day mortality among women and men below 50 years of age.

Methods: A register-based study using data from mandatory national registers, where patients with severe COVID-19 admitted to the ICU with need for mechanical ventilation (cases) between March 2020 and June 2021 were matched regarding age, sex, and district of residence with 10 population-based controls. Both the study population and the controls were divided into groups based on age (< 50 years, 50-64, and ≥ 65 years) and sex. Multivariate logistic regression models including socioeconomic factors were used to calculate odds ratios (OR) with 95% confidence intervals (CIs) for associations between severe COVID-19 in the population to compare the magnitude of the risk associations for co-morbidities in the different age categories, and subsequently factors associated with 90-day mortality among patients admitted to ICU.

Results: In total, 4921 cases and 49,210 controls (median age 63 years, 71% men) were included. The co-morbidities with the strongest associations with severe COVID-19 for the young population compared to older patients were chronic kidney disease (OR 6.80 [3.61-12.83]), type 2 diabetes (OR 6.31 [4.48-8.88]), hypertension (OR 5.09 [3.79-6.84]), rheumatoid arthritis (OR 4.76 [2.29-9.89]), obesity (OR 3.76 [2.88-4.92]), heart failure (OR 3.06 [1.36-6.89]), and asthma (OR 3.04 [2.22-4.16]). When comparing women vs. men < 50 years of age, stronger associations were seen for women regarding type 2 diabetes (OR 11.25 [6.00-21.08] vs OR 4.97 [3.25-7.60]) and hypertension (OR 8.76 [5.10-15.01] vs OR 4.09 [2.86-5.86]). The factors associated with 90-day mortality in the young were previous venous thromboembolism (OR 5.50 [2.13-14.22]), chronic kidney disease (OR 4.40 [1.64-11.78]) and type 2 diabetes (OR 2.71 [1.39-5.29]). These associations with 90-day mortality were foremost driven by the female population.

Conclusion: Chronic kidney failure, type 2 diabetes, hypertension, rheumatoid arthritis, obesity, heart failure, and asthma were the strongest risk factors associated with severe COVID-19 requiring ICU-care in individuals < 50 years compared to the older population. However, after ICU admission, previous thromboembolism, chronic kidney failure, and type 2 diabetes were associated with increased 90-day mortality. The risk associations for co-morbidities were generally stronger among younger individuals compared to older and in women compared to men.

Citing Articles

From Crisis to Complications: A Nationwide Cohort Study Assessing One-Year Cardiovascular and Thromboembolic Risks After Severe COVID-19 Compared to Matched Controls.

Liliequist A, Svensson P, Hofmann R, Habel H, Stahlberg M, Nordberg P J Clin Med. 2024; 13(23).

PMID: 39685724 PMC: 11641933. DOI: 10.3390/jcm13237265.


Response to Letter from Dr. Volbeda and Colleagues Regarding COVID-19 and CKD.

Sorling A, Svensson P Kidney Int Rep. 2023; 8(9):1900-1901.

PMID: 37705918 PMC: 10496072. DOI: 10.1016/j.ekir.2023.07.015.

References
1.
Boyle J, Nowak G, Kinder R, Iachan R, Dayton J . Better Understanding Adult COVID-19 Vaccination Hesitancy and Refusal: The Influence of Broader Beliefs about Vaccines. Int J Environ Res Public Health. 2022; 19(11). PMC: 9180283. DOI: 10.3390/ijerph19116838. View

2.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

3.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View

4.
Xie J, Prats-Uribe A, Feng Q, Wang Y, Gill D, Paredes R . Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19. JAMA Intern Med. 2022; 182(10):1063-1070. PMC: 9389434. DOI: 10.1001/jamainternmed.2022.3858. View

5.
Foldi M, Farkas N, Kiss S, Zadori N, Vancsa S, Szako L . Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis. Obes Rev. 2020; 21(10):e13095. PMC: 7404429. DOI: 10.1111/obr.13095. View